⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

March 1, 1989Journal of Cardiovascular Pharmacology

Pimobendan Increases Survival of Cardiomyopathic Hamsters

View Full Paper

Ask AI

Bookmark

Share

Authors

JMJ. C. A. van MeelUniversity of Amsterdam AMAnnerose B. M. MauzBoehringer Ingelheim (Germany)WWWolfgang WienenBoehringer Ingelheim (Germany)

Discussion

Loading...

Member takes

Implication

Hypothesis-generating for pimobendan in heart failure; human trials needed before any clinical consideration.

Key Points

Key points are not available for this paper at this time.

Cite This Study

Meel et al. (1989) studied this question.

synapsesocial.com/papers/6a70096553da1ffdb5079ac5 https://doi.org/10.1097/00005344-198903000-00021

Topics

View Full Paper

Ask AI

Bookmark

Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Case-control study of the effects of pimobendan on survival time in cats with hypertrophic cardiomyopathy and congestive heart failure2014 · 50 citations
2A Double-Blind, Randomized, Placebo-Controlled Study of Pimobendan in Dogs with Dilated Cardiomyopathy2002 · 94 citations
3A Double-Blind, Randomized, Placebo-Controlled Study of Pimobendan in Dogs with Dilated Cardiomyopathy2002 · 27 citations
4Cardiac Effects of a Single Dose of Pimobendan in Cats With Hypertrophic Cardiomyopathy; A Randomized, Placebo-Controlled, Crossover Study2019 · 35 citations
5Effect of pimobendan on the clinical outcome and survival of cats with non-taurine responsive dilated cardiomyopathy2012 · 61 citations